November 15, 2022 – IAVA’s Associate Director, Government Affairs, Kaitlynne Yancy, hosts a discussion with Dr. Rachael Earls, Sr. Medical Science Liaison with Myriad Genetics, and Brian, a GeneSight-tested patient. In addition to discussing the importance of seeking mental health treatment, the panel shares information about the GeneSight® Psychotropic test, a genetic test that informs clinicians about how a patient’s genes may impact how they metabolize and/or respond to certain medications commonly prescribed for depression, anxiety, ADHD and other psychiatric conditions.